Michael V. Mandola

1 Patent

• US124799172025

  Methods of Treating NSCLC Comprising Administering Platinum Doublet Chemotherapy Followed by an Anti-pd-1 Antibody and an Anti-ctla-4 Antibody

  Bristol-myers Squibb Company

  0 cites